Celon Pharma (8RP.F) Stock Highlights

5.67 | +0.18%

2024-12-21 05:46:00

Celon Pharma SA is a Poland based company engages in the research of therapeutic solutions and development, production, distribution, and marketing of specialized generic products. It invests in the development of innovative pharmaceuticals with potential applications in the treatment of cancer, neurological diseases, diabetes and other metabolic disorders. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir, and Valzek, as well as inhalation powder.

Statistics

Range Today

5.67 5.67

Volume Today 0

Range 1 Year

3.22 7.14

Volume 1 Year 8.85K

Range 3 Year

2.48 7.33

Volume 3 Year 14.09K

Range 10 Year

2.48 11.4

Volume 10 Year 16.32K

Highlights

Market Capitalization 368.69M (small)

Floating Shares 23.82M

Current Price 5.67

Price To Earnings -30.45

Price To Revenue 1.03

Price To Book 0.68

Earnings Per Share -0.2

Dividend Yield 0.31%

Dividend Per Share 0.02

Payout Ratio 0%

Performance

Latest +0.18%

1 Month -2.24%

3 Months -7.5%

6 Months +62.46%

1 Year +59.72%

3 Years -18.42%

5 Years -49.01%

10 Years -49.01%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.